[Treatment of chronic obstructive pulmonary disease--traditional bronchodilatation and targeted anti-inflammatory therapy]. / Leczenie przewleklej obturacyjnej choroby pluc--bronchodylatacja i przeciwzapalna farmakoterapia celowana.
Pneumonol Alergol Pol
; 79(1): 32-8, 2011.
Article
em Pl
| MEDLINE
| ID: mdl-21190151
ABSTRACT
Currently available pharmacological treatment of COPD relies mostly on prophylaxis (smoking cessation) and symptomatic treatment, i.e. inhaled anticholinergic agents, ß2-agonists and phosphodiesterase inhibitors, aiming in their bronchodilatation capacity. Inhaled corticosteroid therapy is mainly prescribed in far advanced stages of the disease and its role in disease modification is still controversial. The authors analize currently available treatment modalities with regards to their potential anti-inflammatory and pleiotropic mode of action, which may lead to disease course modification.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Broncodilatadores
/
Doença Pulmonar Obstrutiva Crônica
/
Anti-Inflamatórios
Tipo de estudo:
Etiology_studies
Limite:
Humans
Idioma:
Pl
Revista:
Pneumonol Alergol Pol
Ano de publicação:
2011
Tipo de documento:
Article